Efficacy of a tetravalent dengue vaccine in children in Latin America. - Wikidata - wikimedia - TriplyDB

Efficacy of a tetravalent dengue vaccine in children in Latin America.

Efficacy of a tetravalent dengue vaccine in children in Latin America.

http://www.wikidata.org/entity/Q34446032

about

The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus Once and future epidemics: Zika virus emerging Predicting Dengue Fever Outbreaks in French Guiana Using Climate Indicators Tackling dengue fever: Current status and challenges The changing epidemiology of dengue in China, 1990-2014: a descriptive analysis of 25 years of nationwide surveillance data Epidemiological Scenario of Dengue in Brazil Tissue Barriers to Arbovirus Infection in Mosquitoes Utility of a Dengue-Derived Monoclonal Antibody to Enhance Zika Infection In Vitro Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients Prospects for dengue vaccines for travelers Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control Serotype influences on dengue severity: a cross-sectional study on 485 confirmed dengue cases in Vitória, Brazil Human antibody response to dengue virus: implications for dengue vaccine design The dengue vaccine pipeline: Implications for the future of dengue control Dengue Vaccine: Considerations before Rollout in Colombia Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies Polyandry Depends on Postmating Time Interval in the Dengue Vector Aedes aegypti Dengue Fever: Causes, Complications, and Vaccine Strategies Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment Recent advances in understanding dengue Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine Reviewing dengue: still a neglected tropical disease?The case for a typhoid vaccine probe study and overview of design elements The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response Public Health Responses to and Challenges for the Control of Dengue Transmission in High-Income Countries: Four Case Studies Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America Dengue vaccine: local decisions, global consequences Vaccines and immunization strategies for dengue prevention Cytotoxic CD4 T Cells: Differentiation, Function, and Application to Dengue Virus Infection Delivering vaccines to the people who need them most Dengue: an update on treatment options The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries The global burden of dengue: an analysis from the Global Burden of Disease Study 2013 Analysis of Dengue Virus Genetic Diversity during Human and Mosquito Infection Reveals Genetic Constraints

P2860

Q22680660-6C5DA565-19E7-4E89-AACA-9371B2C10794 Q24048935-2749D9D4-C63B-401E-A0E7-BC2303A1C783 Q24288738-5C51FAA3-1034-4193-BA03-009945FDF731 Q24288867-87D379CD-154A-49F2-8B38-EA8F209C217F Q24288879-E9BE4E12-7B04-4791-8F96-CD03D467EEAF Q24289012-6B607369-4090-4BF2-BAA0-8DFE1EC5E32C Q24701759-18768BB9-3F4E-4135-B7B6-7AB5003D8ED4 Q25708158-326F82AD-DD6C-4687-91F1-AAB822125CC0 Q26257542-E648BEA0-D893-48A7-BA38-9BB39BC8A9F2 Q26314423-C4C50CB1-04F3-4D77-A5DF-61B69B55F09C Q26314452-7FAD2D00-A153-4278-AECF-500EFF9D513E Q26314515-356C168E-8E5C-4F5B-82ED-9E938EFAA3BE Q26314609-EEFE28D5-F83F-4817-8630-C76ABB724AE6 Q26314683-72824C6D-6704-4E7E-881F-9FBA7FDFE765 Q26314687-A62355A2-E66F-4769-A318-A3CBDEBACE83 Q26314715-A4B04E0E-53FA-4C0B-BA34-EFD04096CE18 Q26315546-C10D7269-6FC4-44AC-88F9-8C40C3694E80 Q26700082-49E10229-4BD5-44EF-B66B-AC8B3B7FC307 Q26700096-1F870CD4-AFDA-4D66-8ABB-AD70C16221F5 Q26700120-41B34AE1-CC65-4D2B-899B-680C8768187F Q26746185-4DBB45C4-AA99-4F42-9BAB-51EC54BB0472 Q26766156-B6660B91-2FA2-4884-B6A7-44667EF9D0DD Q26782367-6E9DAAA8-06EC-40E2-BEC5-DB9C94B3D74F Q26825672-28804A5C-FB97-44B6-B0AC-C77E945BF113 Q26859432-3CD92D5F-C6B6-49E4-8181-88BF1B8DD4E6 Q26995782-83C78C60-0DEE-4FAA-ADD2-55A577188D1A Q27010597-873A0A95-BDAA-41BA-A7A2-A942CA165F5E Q27011190-1F46CA0F-A613-4127-86AD-47D45C2700A7 Q27116692-D337636B-A143-48E4-8AB4-CEAA36DF34E2 Q27304342-DDC26A75-B570-43C7-B09A-E061380D11FB Q27468578-EB68B794-3035-46DD-8BEB-4E3EE6CD9FA6 Q27468944-C015AD57-6B06-4F0B-BFFA-A7FC8B9BEAB4 Q27928072-60550919-D853-4F6C-9066-06DD40415293 Q28077521-0F4F7D69-842B-4B31-8A6F-66B9F0D303B1 Q28079626-3B5B5CDF-6517-424A-ACAB-02F295980CB6 Q28082744-61A5668B-03EC-4A31-9CCF-824E53D26A27 Q28085044-2DCD3041-0899-4A5E-BBBC-77B0CD4D2FE4 Q28354105-532DB3EF-CFCD-432A-8D95-3FB8EBF48589 Q28388682-4918842E-CF39-46C9-990A-F20EDDA20CBC Q28547668-360EEBDD-5FF6-41A8-8ED9-00FA75EF9EE6

P2860

Efficacy of a tetravalent dengue vaccine in children in Latin America.

http://www.wikidata.org/entity/Q34446032

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Efficacy of a tetravalent dengue vaccine in children in Latin America.

@ast

Efficacy of a tetravalent dengue vaccine in children in Latin America.

@en

Efficacy of a tetravalent dengue vaccine in children in Latin America.

@nl

type

label

Efficacy of a tetravalent dengue vaccine in children in Latin America.

@ast

Efficacy of a tetravalent dengue vaccine in children in Latin America.

@en

Efficacy of a tetravalent dengue vaccine in children in Latin America.

@nl

prefLabel

Efficacy of a tetravalent dengue vaccine in children in Latin America.

@ast

Efficacy of a tetravalent dengue vaccine in children in Latin America.

@en

Efficacy of a tetravalent dengue vaccine in children in Latin America.

@nl

P1433

Q34446032-86386F3C-2E3D-4FDC-84B2-9970DA931D9C

P1476

Q34446032-5F042682-CF4A-4900-AAF3-0C9B6D9E8872

P2093

Q34446032-08244DC7-2D80-43B8-9281-2FA78A6997A9

Q34446032-1FCEE3BD-FCA6-4ABB-B12B-CA20FF7D7EF0

Q34446032-34ECA48B-608E-4DF6-BB2C-6A44FC206B46

Q34446032-4B7A608E-8DA4-4D8F-91AF-FF187234A601

Q34446032-4E961951-D8EE-4BB6-A776-74F297DAB1A0

Q34446032-5E18B53B-32AC-4404-A616-6EC69C36B0BD

Q34446032-6820CA6F-809A-4530-87A0-7EE27466D6E1

Q34446032-6BDF1BE6-4E9A-4ED5-BAF1-BE31BECAC54C

Q34446032-7CAAC6A3-994C-4A4B-B5C3-C77E7F2950B2

Q34446032-82F18A30-337C-4E19-B548-1CAB1285C482

P304

Q34446032-11593ED8-63D7-4717-8CA1-12455B0897A8

P31

Q34446032-4C09CC80-EF26-414B-9B3D-F371F7A8A6E4

P356

Q34446032-0CEAF968-9F2C-4F36-A4A7-5BCD68FF024E

P407

Q34446032-B1AA390C-12CD-4D0B-A82C-86E80DD5F332

P433

Q34446032-7F236EA7-2611-422C-B776-F941736EC64B

P478

Q34446032-675F1A46-29A3-49C4-88F8-B352F7B9233A

P50

Q34446032-AE7A3FFE-6FF1-4DCA-811A-BA65CC62BF19

Q34446032-F935EFED-C9EF-4ADA-A65E-1B19B694F34A

P5008

Q34446032-FD51B9BF-9CE7-4BC4-B42D-61FC0A99A371

P577

Q34446032-3B77D372-AE27-4F8C-8604-444EF93FDB34

P698

Q34446032-FD05B98C-A1BE-4AD5-B2F6-B2390278B6ED

P921

Q34446032-E33693C0-7580-42E1-82CC-DA6931263EE0

P356

P1433

The New England Journal of Medicine

P1476

Efficacy of a tetravalent dengue vaccine in children in Latin America

@en

P2093

Betzana Zambrano

http://www.w3.org/2001/XMLSchema#string

CYD15 Study Group

http://www.w3.org/2001/XMLSchema#string

Carmen Deseda

http://www.w3.org/2001/XMLSchema#string

Doris Maribel Rivera

http://www.w3.org/2001/XMLSchema#string

Edith Langevin

http://www.w3.org/2001/XMLSchema#string

Enrique Rivas

http://www.w3.org/2001/XMLSchema#string

Fernando Noriega

http://www.w3.org/2001/XMLSchema#string

Gabriel Carrasquilla

http://www.w3.org/2001/XMLSchema#string

Gustavo Horacio Dayan

http://www.w3.org/2001/XMLSchema#string

Humberto Reynales

http://www.w3.org/2001/XMLSchema#string

P304

113-123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1411037

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

372

http://www.w3.org/2001/XMLSchema#string

P50

Reynaldo Dietze

J L Arredondo-Garcia

P5008

P577

2014-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25365753

http://www.w3.org/2001/XMLSchema#string

P921